Integrating Network Pharmacology and Experimental Validation to Identifying Key Herbal Components and Targets for Liver Cancer
Fang Wang(Hebei Medical University), Huimin Yan(Hebei Medical University), Xiling Liu(Hebei Medical University), Yi Xu(Zhejiang Chinese Medical University), Shenghao Li(Hebei Medical University)
Cited by 2
Related Papers
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
|Journal of Inflammation Research|2024|61
Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells
|Oncology Letters|2018|58
The current status and future of PD-L1 in liver cancer
|Frontiers in Immunology|2023|55
Antimalarial Dihydroartemisinin triggers autophagy within HeLa cells of human cervical cancer through Bcl-2 phosphorylation at Ser70
|Phytomedicine|2018|52
Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1
|Molecular and Cellular Biochemistry|2020|51